Literature DB >> 1252372

Effects of sulphydryl compounds on abnormal red cell pyruvate kinase.

A Zanella, P Rebulla, A M Giovanetti, M Curzio, G P Pescarmona, G Sirchia.   

Abstract

The effect of some sulphydryl compounds on two new variants of red cell pyruvate kinase (ATP: pyruvate phosphotransferase, PK) is reported. In vitro a striking correction has been obtained of both the qualitative and, in one case, the quantitative defect of red cell PK. In vivo, a correction of the qualitative and quantitative abnormalities has been produced in both patients, with clinical improvement of one of them. These findings, together with the unexpected results in respect to the functional properties of PK found in the affected members of the two families studied, suggest that the PK abnormality is not the cause of the haemolytic anaemia, but an epiphenomenon of a primary unknown defect that apparently involves the red cell thiol groups.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1252372     DOI: 10.1111/j.1365-2141.1976.tb00941.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Search for a relationship between molecular anomalies of the mutant erythrocyte pyruvate kinase variants and their pathological expression.

Authors:  A Kahn; J Marie; J L Vives-Corrons; P Maigret; A Najman
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

Review 3.  Erythrocyte pyruvate kinase deficiency: 2015 status report.

Authors:  Rachael F Grace; Alberto Zanella; Ellis J Neufeld; D Holmes Morton; Stefan Eber; Hassan Yaish; Bertil Glader
Journal:  Am J Hematol       Date:  2015-08-14       Impact factor: 10.047

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.